Moderna, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 150.89 | 10,000 | 1,508,900 | 7,524,880 | 7.5 M to 7.5 M (-0.13 %) |
| Feb 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 6,433,868 | 6.4 M to 6.4 M (-0.02 %) |
| Feb 26 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 150.41 | 9,000 | 1,353,690 | 6,434,868 | 6.4 M to 6.4 M (-0.14 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 597,431 | |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 150.41 | 5,000 | 752,050 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 150.62 | 5,300 | 798,286 | 1,614,597 | 1.6 M to 1.6 M (-0.33 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 149.98 | 685 | 102,736 | 1,619,897 | 1.6 M to 1.6 M (-0.04 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 148.78 | 800 | 119,024 | 1,620,582 | 1.6 M to 1.6 M (-0.05 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 147.85 | 1,551 | 229,315 | 1,621,382 | 1.6 M to 1.6 M (-0.10 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 146.73 | 1,200 | 176,076 | 1,622,933 | 1.6 M to 1.6 M (-0.07 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 145.48 | 1,100 | 160,028 | 1,624,133 | 1.6 M to 1.6 M (-0.07 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 144.58 | 1,564 | 226,123 | 1,625,233 | 1.6 M to 1.6 M (-0.10 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 143.49 | 1,300 | 186,537 | 1,626,797 | 1.6 M to 1.6 M (-0.08 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 141.61 | 300 | 42,483 | 1,628,097 | 1.6 M to 1.6 M (-0.02 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 140.15 | 200 | 28,030 | 1,628,397 | 1.6 M to 1.6 M (-0.01 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 139.14 | 200 | 27,828 | 1,628,597 | 1.6 M to 1.6 M (-0.01 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 137.97 | 300 | 41,391 | 1,628,797 | 1.6 M to 1.6 M (-0.02 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 136.83 | 500 | 68,415 | 1,629,097 | 1.6 M to 1.6 M (-0.03 %) |
| Feb 25 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,629,597 | 1.6 M to 1.6 M (+0.62 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 150.41 | 35,000 | 5,264,350 | 12,869,462 | 12.9 M to 12.9 M (-0.27 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.91 | 99,005 | 14,742,765 | 12,904,462 | 13 M to 12.9 M (-0.76 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.01 | 267,038 | 39,523,921 | 13,003,467 | 13.3 M to 13 M (-2.01 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 147.17 | 288,656 | 42,481,157 | 13,270,505 | 13.6 M to 13.3 M (-2.13 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 146.05 | 351,112 | 51,281,277 | 13,559,161 | 13.9 M to 13.6 M (-2.52 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 145.04 | 354,358 | 51,396,616 | 13,910,273 | 14.3 M to 13.9 M (-2.48 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 144.17 | 358,528 | 51,688,838 | 14,264,631 | 14.6 M to 14.3 M (-2.45 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 151.29 | 23,423 | 3,543,551 | 14,623,159 | 14.6 M to 14.6 M (-0.16 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 150.51 | 190,710 | 28,704,468 | 14,646,582 | 14.8 M to 14.6 M (-1.29 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 149.63 | 179,268 | 26,823,154 | 14,837,292 | 15 M to 14.8 M (-1.19 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.52 | 268,688 | 39,905,810 | 15,016,560 | 15.3 M to 15 M (-1.76 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 147.57 | 292,483 | 43,162,565 | 15,285,248 | 15.6 M to 15.3 M (-1.88 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 146.64 | 307,795 | 45,134,105 | 15,577,731 | 15.9 M to 15.6 M (-1.94 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 145.48 | 357,316 | 51,982,439 | 15,885,526 | 16.2 M to 15.9 M (-2.20 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 144.55 | 405,551 | 58,623,573 | 16,242,842 | 16.6 M to 16.2 M (-2.44 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 143.57 | 397,126 | 57,017,127 | 16,648,393 | 17 M to 16.6 M (-2.33 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 142.76 | 117,011 | 16,704,549 | 17,045,519 | 17.2 M to 17 M (-0.68 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 141.46 | 70,631 | 9,991,271 | 17,162,530 | 17.2 M to 17.2 M (-0.41 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 140.24 | 102,852 | 14,423,553 | 17,233,161 | 17.3 M to 17.2 M (-0.59 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 139.65 | 56,435 | 7,880,849 | 17,336,013 | 17.4 M to 17.3 M (-0.32 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 138.56 | 46,222 | 6,404,451 | 17,392,448 | 17.4 M to 17.4 M (-0.27 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 137.29 | 122,142 | 16,768,948 | 17,438,670 | 17.6 M to 17.4 M (-0.70 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 136.48 | 9,985 | 1,362,773 | 17,560,812 | 17.6 M to 17.6 M (-0.06 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 170.03 | 30,968 | 5,265,421 | 17,570,797 | 17.6 M to 17.6 M (-0.18 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 169.14 | 54,274 | 9,179,910 | 17,601,735 | 17.7 M to 17.6 M (-0.31 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 168.11 | 58,377 | 9,813,857 | 17,656,009 | 17.7 M to 17.7 M (-0.33 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 167.10 | 122,715 | 20,505,750 | 17,714,386 | 17.8 M to 17.7 M (-0.69 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 166.30 | 351,578 | 58,466,296 | 17,837,101 | 18.2 M to 17.8 M (-1.93 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 165.47 | 165,578 | 27,397,976 | 18,188,311 | 18.4 M to 18.2 M (-0.90 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 164.14 | 189,200 | 31,054,266 | 18,353,889 | 18.5 M to 18.4 M (-1.02 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 163.25 | 366,471 | 59,827,380 | 18,543,089 | 18.9 M to 18.5 M (-1.94 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 162.36 | 250,501 | 40,672,044 | 18,909,560 | 19.2 M to 18.9 M (-1.31 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 160.96 | 30,808 | 4,958,809 | 19,160,061 | 19.2 M to 19.2 M (-0.16 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 160.37 | 54,409 | 8,725,620 | 19,190,869 | 19.2 M to 19.2 M (-0.28 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 159.18 | 161,887 | 25,769,076 | 19,245,278 | 19.4 M to 19.2 M (-0.83 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 644,822 | |
| Feb 24 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 166.63 | 5,000 | 833,150 | 0 | 5 K to 0 (-100.00 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 6,478 | |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 169.81 | 100 | 16,981 | 0 | 100 to 0 (-100.00 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 168.90 | 281 | 47,461 | 100 | 381 to 100 (-73.75 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 168.00 | 356 | 59,808 | 381 | 737 to 381 (-48.30 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 166.82 | 700 | 116,774 | 737 | 1.4 K to 737 (-48.71 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 165.95 | 1,000 | 165,950 | 1,437 | 2.4 K to 1.4 K (-41.03 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 164.60 | 300 | 49,380 | 2,437 | 2.7 K to 2.4 K (-10.96 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 163.57 | 1,100 | 179,927 | 2,737 | 3.8 K to 2.7 K (-28.67 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 162.47 | 800 | 129,976 | 3,837 | 4.6 K to 3.8 K (-17.25 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 160.38 | 100 | 16,038 | 4,637 | 4.7 K to 4.6 K (-2.11 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 159.32 | 263 | 41,901 | 4,737 | 5 K to 4.7 K (-5.26 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 178.91 | 600 | 107,346 | 154,660 | 155.3 K to 154.7 K (-0.39 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 177.89 | 500 | 88,945 | 155,260 | 155.8 K to 155.3 K (-0.32 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 177.00 | 1,300 | 230,100 | 155,760 | 157.1 K to 155.8 K (-0.83 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 175.92 | 1,100 | 193,512 | 157,060 | 158.2 K to 157.1 K (-0.70 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 174.82 | 1,846 | 322,718 | 158,160 | 160 K to 158.2 K (-1.15 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 173.86 | 3,800 | 660,668 | 160,006 | 163.8 K to 160 K (-2.32 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 172.88 | 1,200 | 207,456 | 163,806 | 165 K to 163.8 K (-0.73 %) |
| Feb 22 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.64 | 700 | 120,148 | 165,006 | 165.7 K to 165 K (-0.42 %) |
| Feb 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.80 | 10,000 | 1,718,000 | 7,534,880 | 7.5 M to 7.5 M (-0.13 %) |
| Feb 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 6,443,868 | 6.4 M to 6.4 M (-0.02 %) |
| Feb 19 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 174.28 | 9,000 | 1,568,520 | 6,444,868 | 6.5 M to 6.4 M (-0.14 %) |
| Feb 17 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 607,431 | |
| Feb 17 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 182.80 | 15,000 | 2,742,000 | 1,619,597 | 1.6 M to 1.6 M (-0.92 %) |
| Feb 17 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,634,597 | 1.6 M to 1.6 M (+0.62 %) |
| Feb 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 178.29 | 10,000 | 1,782,900 | 7,544,880 | 7.6 M to 7.5 M (-0.13 %) |
| Feb 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | A | 0.00 | 6,963 | 0 | 6,963 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | A | 179.52 | 32,023 | 5,748,769 | 32,023 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Meline David W | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,570 | 0 | 5,570 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Meline David W | Chief Financial Off ... | Option Exercise | A | 179.52 | 25,618 | 4,598,943 | 25,618 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | A | 0.00 | 8,355 | 0 | 8,355 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | A | 179.52 | 38,428 | 6,898,595 | 38,428 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Option Exercise | A | 179.52 | 144,105 | 25,869,730 | 144,105 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 6,453,868 | 6.5 M to 6.5 M (-0.02 %) |
| Feb 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 182.74 | 9,000 | 1,644,660 | 6,454,868 | 6.5 M to 6.5 M (-0.14 %) |
| Feb 09 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 654,822 | |
| Feb 09 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 176.98 | 5,000 | 884,900 | 0 | 5 K to 0 (-100.00 %) |
| Feb 09 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 176.69 | 1,505 | 265,918 | 176,752 | 178.3 K to 176.8 K (-0.84 %) |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 175.78 | 2,641 | 464,235 | 178,257 | 180.9 K to 178.3 K (-1.46 %) |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 174.72 | 2,700 | 471,744 | 180,898 | 183.6 K to 180.9 K (-1.47 %) |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 173.59 | 2,600 | 451,334 | 183,598 | 186.2 K to 183.6 K (-1.40 %) |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 172.44 | 1,200 | 206,928 | 186,198 | 187.4 K to 186.2 K (-0.64 %) |
| Feb 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.48 | 400 | 68,592 | 187,398 | 187.8 K to 187.4 K (-0.21 %) |
| Feb 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 166.42 | 10,000 | 1,664,200 | 7,554,880 | 7.6 M to 7.6 M (-0.13 %) |
| Feb 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 6,463,868 | 6.5 M to 6.5 M (-0.02 %) |
| Feb 05 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 156.51 | 9,000 | 1,408,590 | 6,464,868 | 6.5 M to 6.5 M (-0.14 %) |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 617,431 | |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 627,431 | |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 156.51 | 10,000 | 1,565,100 | 1,629,597 | 1.6 M to 1.6 M (-0.61 %) |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,639,597 | 1.6 M to 1.6 M (+0.61 %) |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 158.40 | 10,000 | 1,584,000 | 1,629,597 | 1.6 M to 1.6 M (-0.61 %) |
| Feb 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,639,597 | 1.6 M to 1.6 M (+0.61 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Le Goff Corinne | Chief Commercial Of ... | Option Exercise | A | 0.00 | 25,400 | 0 | 25,400 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Le Goff Corinne | Chief Commercial Of ... | Option Exercise | A | 0.00 | 25,400 | 0 | 25,400 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Le Goff Corinne | Chief Commercial Of ... | Option Exercise | A | 157.48 | 58,563 | 9,222,501 | 58,563 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Le Goff Corinne | Chief Commercial Of ... | Option Exercise | A | 157.48 | 58,563 | 9,222,501 | 58,563 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 659,822 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 172.99 | 5,000 | 864,950 | 0 | 5 K to 0 (-100.00 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 169,952 | |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 174.00 | 100 | 17,400 | 0 | 100 to 0 (-100.00 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 172.86 | 700 | 121,002 | 100 | 800 to 100 (-87.50 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 171.30 | 100 | 17,130 | 800 | 900 to 800 (-11.11 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 165.32 | 200 | 33,064 | 900 | 1.1 K to 900 (-18.18 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 164.20 | 600 | 98,520 | 1,100 | 1.7 K to 1.1 K (-35.29 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 163.07 | 300 | 48,921 | 1,700 | 2 K to 1.7 K (-15.00 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 162.00 | 300 | 48,600 | 2,000 | 2.3 K to 2 K (-13.04 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 160.33 | 300 | 48,099 | 2,300 | 2.6 K to 2.3 K (-11.54 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 159.20 | 800 | 127,360 | 2,600 | 3.4 K to 2.6 K (-23.53 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 158.28 | 400 | 63,312 | 3,400 | 3.8 K to 3.4 K (-10.53 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 157.28 | 800 | 125,824 | 3,800 | 4.6 K to 3.8 K (-17.39 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 156.16 | 400 | 62,464 | 4,600 | 5 K to 4.6 K (-8.00 %) |
| Feb 02 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 183.84 | 200 | 36,768 | 187,798 | 188 K to 187.8 K (-0.11 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 182.56 | 49 | 8,945 | 187,998 | 188 K to 188 K (-0.03 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 179.96 | 100 | 17,996 | 188,047 | 188.1 K to 188 K (-0.05 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 178.68 | 500 | 89,340 | 188,147 | 188.6 K to 188.1 K (-0.27 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 177.43 | 400 | 70,972 | 188,647 | 189 K to 188.6 K (-0.21 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 176.58 | 600 | 105,948 | 189,047 | 189.6 K to 189 K (-0.32 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 175.44 | 400 | 70,176 | 189,647 | 190 K to 189.6 K (-0.21 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 174.13 | 2,000 | 348,260 | 190,047 | 192 K to 190 K (-1.04 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 173.21 | 1,697 | 293,937 | 192,047 | 193.7 K to 192 K (-0.88 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 172.23 | 2,000 | 344,460 | 193,744 | 195.7 K to 193.7 K (-1.02 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.04 | 1,300 | 222,352 | 195,744 | 197 K to 195.7 K (-0.66 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 170.01 | 700 | 119,007 | 197,044 | 197.7 K to 197 K (-0.35 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 169.09 | 800 | 135,272 | 197,744 | 198.5 K to 197.7 K (-0.40 %) |
| Feb 01 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 167.51 | 300 | 50,253 | 198,544 | 198.8 K to 198.5 K (-0.15 %) |